Powered by lexis nexis

RXi Pharmaceuticals to Present at the 5th Annual Cancer BioPartnering & Investment Forum

Mar 22, 2017 - PR Newswire

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, today announced Alexey Eliseev, PhD, RXi's Chief Business Officer, will present at the 5th Annual Cancer BioPartnering & Investment Forum. The forum will provide a platform to present to and meet with thought leaders from cancer research institutes, leading pharmaceutical and biotech companies as well as institutional investors. This eve...